Concepedia

Steve Weitman

SW

Statistics

Publications

27

Citations

2.7K

H-Index

23

Active since

1999

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

The University of Texas at Austin

St. Jude Children's Research Hospital

The University of Texas MD Anderson Cancer Center

Université de Montréal

Steve Weitman is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, oncology, and pharmacy.

Publications per year

1999–2018

27

Publications

27

Biodegradable block copolymers for delivery of proteins and water-insoluble drugs

Gaylen M. Zentner, Ramesh Rathi, Chung Shih et al. · Journal of Controlled Release · 2001 · 584 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.

Cory L. Grand, Haiyong Han, Rubén M. Muñoz et al. · PubMed · 2002 · 370 citations

Medicine, Molecular Biology, Oncology +17

Antitumor Activity of a Kinesin Inhibitor

Roman Sakowicz, Jeffrey T. Finer, Christophe Béraud et al. · Cancer Research · 2004 · 241 citations

Life Sciences, Molecular Biology, Oncology +17

Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.

Dirk B. Mendel, Alexander Laird, Beverly D. Smolich et al. · PubMed · 2000 · 234 citations

Medicine, Oncology, Pharmacology +17

A phase I study of irinotecan in pediatric patients: a pediatric oncology group study.

Susan M. Blaney, Stacey L. Berg, Charles B. Pratt et al. · PubMed · 2001 · 117 citations

Medicine, Oncology, Pharmacology +16

1–5 of 27